Metropolis Healthcare logo

Metropolis Healthcare financials: balance sheet, profit and loss, cash flow

NSE: METROPOLISBSE: 542650Healthcare ServicesSmall Cap

Metropolis Healthcare Limited · Face value ₹2 · Listed Apr 2019 · Issue price ₹880
Last close ₹545.65down ₹8.20 (1.48%)BSE ₹545.15

Share price at the NSE close on 30 Oct 2026. Previous close ₹553.85.

30 Oct: open ₹551.20, high ₹556.70, low ₹541.15

52-week range of traded prices to 30 Oct 2026
₹412.25Low, 2 Apr 2026₹609.05High, 30 Jul 2026
Market cap
₹11,320 Cr557th largest listed
P/E
56.14
P/B
7.48
Dividend yield
0.37%
ROE
14.2%
ROCE
18.6%
Debt to equity
0.01
Volume, NSE
49,77547.5% delivered

Metropolis Healthcare's financial statements for the 8 years to Mar 2026, consolidated: the company and its subsidiaries together, with the twelve months to Jun 2026 after them.

8 years at a glance

₹ crore, years to March.Metropolis Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
76112418Mar 198561280Mar 209981830Mar 211,228215259Mar 221,14814379Mar 231,2081280Mar 241,33114614Mar 251,64619119Mar 26
Peak revenue ₹1,646 Cr, year to Mar 2026; lowest ₹761 Cr, year to Mar 2019

Operating and net margin, per cent

  • Operating margin
  • Net margin
28.7%10.6%26.3%27.2%28.7%27.9%25.1%23.4%22.8%24.4%16.2%14.9%18.4%17.5%12.5%10.6%10.9%11.6%Mar 19Mar 20Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 6.3% of operating profit in the first full year.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,646
  2. Materials and goods−325
  3. Employee costs−377
  4. Other expenses−543
  5. Operating profit401
  6. Depreciation−134
  7. Other income+26
  8. One-off items−9.0
  9. Finance costs−25
  10. Profit before tax259
  11. Tax−68
  12. Net profit191

What the company owns

  • Plant, investments and other assets₹1,719 Cr
  • Receivables₹170 Cr
  • Current investments₹141 Cr
  • Cash and bank₹62 Cr
  • Inventory₹45 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,525 Cr
  • Other liabilities₹465 Cr
  • Owed to suppliers₹129 Cr
  • Borrowings₹19 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Metropolis Healthcare quarterly results

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026Filed 13 MayJun 2026Twelve monthsFiled 4 Aug
Revenue from operations7618569981,2281,1481,2081,3311,6461,710
5616247128868609251,0281,2451,288
Materials and goods bought174204252276253243269325333
Employee costs176190199233253276314377392
Other expenses211229261376354407446543563
Operating profit before depreciation200233286343288283303401422
Operating margin26.3%27.2%28.7%27.9%25.1%23.4%22.8%24.4%24.7%
Materials, % of revenue22.8%23.8%25.3%22.5%22.1%20.1%20.2%19.7%19.4%
Employee costs, % of revenue23.1%22.2%19.9%19.0%22.0%22.8%23.6%22.9%22.9%
Other expenses, % of revenue27.7%26.8%26.2%30.6%30.8%33.7%33.5%33.0%32.9%
Depreciation and amortisation203946638994109134135
Operating profit after depreciation180194240280199188194267287
Other income891218159152623
Finance costs188202723192526
Profit before one-off items and tax188194244277188175191268285
One-off items−1−25016000−9−9
Profit before tax187169244293188175191259276
634161794446456873
Share of profit of joint ventures and associates–−1–––––––
124128183215143128146191203
Other comprehensive income1−3−1−20−10510
Total comprehensive income125125182212143128145196213
Net margin16.2%14.9%18.4%17.5%12.5%10.6%10.9%11.6%11.9%
Net margin without joint ventures and associates–15.0%–––––––

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026Filed 13 May
4205257088889911,0991,3351,525
4195237078869881,0961,3311,513
Share capital1010101010101041
Reserves4095136968769781,0861,3211,472
Belonging to outside owners of subsidiaries121223411
18002597901419
124169204302265246294334
85892341246210238279
Total assets5537521,0041,5301,5021,5551,8672,138
2483553961,1371,1991,2391,5211,669
305397608393303316346469
Net debt−94−223−42878−27−124−104−184
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026Filed 13 May
249253247264263351
315336294305310397
−15−16738−13−4
Receivables−161216−12−9−49
Inventories−16−87620
Payables23−17−565−2
Other working capital−6−4−1038−1147
Tax paid−57−83−52−37−45−47
Interest paid0010002
Capital spending283153644343
Free cash flow221223194200219307
62−73547−89−201−223
−33163−292−181−87−115
Dividends paid414141201821
Shares bought back000007
Shares issued000000
Net change in cash278−3192−7−2512
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Metropolis Healthcare dividend history

₹ per shareMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026Filed 13 May
₹6.02₹6.34₹8.99₹10.47₹6.98₹6.24₹7.07₹9.19
As stated that year₹24.06₹25.36₹35.97₹41.87₹27.91₹24.95₹28.29₹9.19
₹6.01₹6.31₹8.95₹10.42₹6.95₹6.22₹7.04₹9.19
–₹2.00₹2.00₹2.00₹2.00₹1.00–₹2.00
₹20.85₹25.85₹34.56₹43.30₹48.24₹53.50₹64.24₹72.98
Dividend payout–31.8%22.3%19.1%28.7%16.0%–21.8%
Shareholder yield––0.4%0.4%0.6%0.2%0.2%0.3%
Market cap at the year end (₹ crore)–6,44511,45410,4176,3928,8298,0218,996
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from. The dividend as declared is blank for the year to Mar 2026: its payments were declared on different share counts, a split or bonus between them, so they do not add to one figure.

Ratios

Consolidated, years to March.Metropolis Healthcare PE ratio and valuation

RatioMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 13 MayMar 2026Filed 13 May
Revenue growth–12.5%16.5%23.1%−6.5%5.2%10.2%23.6%
Operating profit growth–16.2%22.8%19.9%−15.9%−2.0%7.2%32.3%
Net profit growth–3.2%43.7%17.1%−33.2%−10.4%13.3%31.4%
Earnings per share growth–5.4%41.8%16.4%−33.3%−10.6%13.4%29.9%
28.7%27.0%29.8%26.9%15.2%12.3%11.9%13.4%
–−1.7 pts2.7 pts−2.9 pts−11.6 pts−3.0 pts−0.3 pts1.4 pts
From the net margin–−1.7 pts6.3 pts−1.5 pts−7.7 pts−2.3 pts0.4 pts0.7 pts
From asset turnover–−1.3 pts−4.5 pts−4.2 pts−4.2 pts0.6 pts−0.2 pts0.7 pts
From borrowing–1.3 pts0.9 pts2.8 pts0.2 pts−1.3 pts−0.5 pts0.0 pts
Return on capital employed41.2%36.9%33.9%24.4%18.6%17.1%14.4%17.3%
Cash conversion––135.8%118.0%172.3%205.6%180.6%183.4%
Interest cover339.523.230.914.27.48.310.510.9
Debt to equity0.040.000.000.290.080.000.010.01
Receivable days6655454039384138
Inventory days5544596864586551
Payable days90152160136136150171146
Cash conversion cycle, days30−54−56−29−33−53−65−57
Working capital days422−93−6−16−16−11
Asset turnover1.381.311.140.970.760.790.780.82
Assets per rupee of net worth1.321.391.431.591.621.471.411.41
Sales per rupee of plant6.527.078.678.828.377.757.007.64
Capital spending to depreciation––0.620.490.590.670.400.33
Plant being built, % of plant in use–0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
9.5%
Cash from operations against operating profit
87.5%
Measure5 years3 years
Revenue growth, yearly rate10.5%12.8%
Profit growth, yearly rate0.7%10.0%
Return on equity, average15.9%12.5%
Return on capital employed, average18.4%16.3%
Operating margin, average24.7%23.5%
Net margin, average12.6%11.1%
Asset turnover, average0.820.80
Cash conversion cycle, days, average−47−58
Interest cover, average10.39.9
Debt to equity, average0.080.01

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations1,378878351
Cash from investing−1,202−514−223
Cash from financing−513−383−115
Capital spending23415143
Dividends paid1426021
Shares bought back777
Shares issued for cash000
Borrowings raised60000
Borrowings repaid600800

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––545758
Altman Z-scorePublished threshold 1.81–20.4226.4712.089.6913.8511.2311.05
Beneish M-scorePublished threshold −1.78––−2.81−2.25−2.78−2.78−2.63−2.71
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––−14.5054.95−9.93−3.024.903.18
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––1.381.571.851.89
Receivables growth less revenue growthOur threshold 0 percentage points–−18.79−20.64−12.91−3.51−1.586.93−8.54
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−24.1742.6516.58−4.50−9.0012.87−25.69
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–−0.610.261.060.37−0.280.401.09
Assets under construction, years of additionsOur threshold 2 years of additions–0.000.000.000.000.000.000.00
Effective tax ratePublished threshold 17.16 per cent33.7424.3324.9626.8223.5226.4723.7626.23
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––−1.31−3.985.070.318.26
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
22 Sep 2026CRISIL Ratings LimitedNon-convertible debenturesCrisil AA-Review, OtherPositive50
22 Sep 2026CRISIL Ratings LimitedBank FacilitiesCrisil AA-Review, OtherPositive295
22 Sep 2026CRISIL Ratings LimitedBank FacilitiesCrisil A1+Review, Re-affirm5
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.